We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

HORIBA Medical

HORIBA ABX designs, develops and distributes worldwide, in vitro diagnostic systems for biological analysis in medica... read more Featured Products: More products

Download Mobile App





HORIBA Medical Shows Latest Yumizen G Range at Lab Trade Show

By LabMedica International staff writers
Posted on 31 Jan 2019
HORIBA Medical (Montpellier, France) showcased its latest Yumizen G range of systems for coagulation diagnostics at MedLab Middle East 2019, which was held in Dubai, UAE, and saw more than 19,610 unique visitors and 678+ exhibitors sharing the most recent technology available in the IVD, and medical laboratory market.

HORIBA Medical specializes in blood cell analysis and recently launched its new and comprehensive range of Yumizen G systems and reagents for coagulation diagnostics. More...
The company’s Yumizen G systems are user friendly, efficient and secure. In combination with specifically developed and optimized ready-to-use reagents, Yumizen G provides a high quality and cost-effective range of hemostasis solutions that will fit any laboratory size or requirement.

Among its new Yumizen G systems for coagulation diagnostics exhibited by HORIBA Medical at MedLab Middle East 2019 was the Yumizen G1550. This fully automated, high capacity analyzer is designed for managing the coagulation diagnostics and monitoring the requirements of clinical laboratories with mid- to high-workloads. Some of its unique features include optional closed tube version and positive tube identification during sampling for safer tube management; continuous volume control for optimal reagent management; and dynamic control of measuring curve & analytical alarms for verified results.

The company also displayed the Yumizen H550, a compact six part-differential hematology analyzer with an auto sampling system. The Yumizen H550 aims to provide full walk away capability to a variety of clinical environments, including hospitals, satellite labs, emergency care, small independent labs, and doctors’ offices.

At MedLab Middle East 2019, HORIBA Medical introduced its new Yumizen D-Dimer reagent kit used for the exclusion of venous thromboembolic disease. The unique and fully adapted reagent kit has been developed for HORIBA Medical’s Yumizen G hemostasis range of fully automated and semi-automated instruments.


Gold Member
Veterinary Hematology Analyzer
Exigo H400
Serological Pipet Controller
PIPETBOY GENIUS
New
Multilevel Whole Blood Calibrator Set
6PLUS1
New
See-Saw Rocking Shaker
SH-200D-S-L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Non-coding RNAs CBR3-AS1 and PCA3 can be utilized as therapeutic targets and prognostic biomarkers in gastric cancer (Photo courtesy of Adobe Stock)

Promising Molecular Markers Support Earlier Diagnosis of Gastric Cancer

Late detection continues to make gastric cancer one of the leading causes of cancer-related deaths globally. With improved early detection tools urgently needed, researchers have now identified two long... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Pathology

view channel
Image: The new technology combines a rapid hemoglobin test with a smartphone app (Photo courtesy of 123RF)

Smartphone-Based Rapid Hemoglobin Test Accurately Detects Colorectal Cancer

Despite the availability of colorectal cancer screening programs, participation remains low, especially for fecal immunochemical tests (FIT), a non-invasive method to detect hidden blood in the stool.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.